Log in
Enquire now
‌

US Patent 10472363 SGC stimulators

Patent 10472363 was granted and assigned to Cyclerion Therapeutics on November, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Cyclerion Therapeutics
Cyclerion Therapeutics
0
Current Assignee
Cyclerion Therapeutics
Cyclerion Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104723630
Patent Inventor Names
Thomas Wai-Ho Lee0
Joon Jung0
Paul Allan Renhowe0
Rajesh R. Iyengar0
Glen Robert Rennie0
Date of Patent
November 12, 2019
0
Patent Application Number
156937580
Date Filed
September 1, 2017
0
Patent Citations Received
‌
US Patent 10858363 SGC stimulators
Patent Primary Examiner
‌
Golam M. Shameem
0
Patent abstract

The present disclosure relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations comprising them and their uses thereof, alone or in combination with one or more additional agents, for treating various diseases, wherein an increase in the concentration of nitric oxide (NO) or an increase in the concentration of cyclic Guanosine Monophosphate (cGMP), or both, or an upregulation of the NO pathway is desirable. The compounds are of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10472363 SGC stimulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.